UBS Reiterates Neutral Rating on CME Group (CME), Estimates Lowered
Tweet Send to a Friend
UBS analyst Alex Kramm reiterated a Neutral rating and $280.00 price target on CME Group (NASDAQ: CME).The analyst commented, "Following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
